Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, and Radiobotics ApS, a leader in AI-powered MSK radiology solutions, has announced that they have entered into a strategic merger agreement. Closing of the transaction is subject to receipt of Danish foreign direct investment (FDI) approval and other…

Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags an important opportunity for MedTech suppliers to engage with government on preparation for the introduction of value based procurement. The Department of Health and Social Care (DHSC) has launched a new industry readiness…

The UK has a unique asset: millions of longitudinal health records built over decades across a diverse population. From births and vaccinations to cancer diagnoses and mental health treatments, this data holds extraordinary potential to improve medical research and accelerate the development of new medicines. Yet that potential has not…

Whether it’s the smooth articulation of a surgical robot, the precise positioning of an imaging system, or the reliable, repeatable movement inside a laboratory instrument, motion control plays a key role in modern medical devices. Despite this, however, it is often one of the most complex aspects of a medical…

Carea, a pregnancy and postnatal wellbeing app, is bridging this gap with the launch of its new Trying to Conceive: IVF/IUI Mode, to support the tens of thousands of women undergoing complex fertility treatment, amid growing concern over inconsistent clinic continuity and limited day-to-day guidance.  While IVF is framed as…

Medi-Globe has announced the launch of mAI Companion, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS), addressing what it says is one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes. Developed through a multi‑year collaboration…

MiraDx, a molecular diagnostics company focused on genetic testing to personalise cancer treatment, has announced the U.S. commercial launch of PROSTOX Standard, a new, clinically validated genetic test that expands access to personalised radiation therapy for patients with localised prostate cancer. The test identifies those at increased risk of developing…

Orthonika, a MedTech spin-out from Imperial College London, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its novel Total Meniscus Replacement (TMR) implant. The company has also been invited to participate in the FDA’s Total Product Life Cycle Advisory Program (TAP), designed to…